2016-05-30-世界卫生组织-Diabetes_Afghanistan_2016_country_profile_1页_339kb

Afghanistan Diabetes Profile Summary

Population and Income:

• Total population: 32.5 million.
• Income group: Low.

Mortality Data:

• Diabetes deaths ages 30–69: Males 850, Females 1070.
• Deaths attributable to high blood glucose ages 30–69: Males 3530, Females 3120.
• Diabetes deaths ages 70+: Males 490, Females 760.
• Mortality estimates are based on uncertain data.

Mortality Proportions:

• CVD: 35%
• Injuries: 19%
• Diabetes: 17%
• Cancer: 6%
• Other NCDs and communicable/maternal conditions not quantified.

Diabetes Prevalence and Risk Factors:

• Diabetes prevalence ages 30–69/all ages: 8.4% (males 8.0%, females 8.8%).
• Overweight prevalence: 13.9% (males 11.8%, females 16.1%).
• Obesity prevalence: 2.4% (males 1.5%, females 3.3%).
• Physical inactivity data not available.

National Response:

• No operational policies or guidelines for diabetes, overweight/obesity, or physical inactivity.
• No evidence-based guidelines, monitoring systems, or diabetes registry.
• No recent national risk factor survey with blood glucose measurement in the public health sector.

Availability of Medicines and Technologies:

• Medicines: Insulin generally available; Metformin available; Sulphonylurea not generally available (DK).
• Basic technologies: Blood glucose measurement available; Oral glucose tolerance test usually not available; HbA1c test sometimes not available (DK).
• Diagnostic/procedures: Dilated fundus examination available; Foot vibration test usually not available; Renal replacement therapy available. Awake